Gitanjali M. Lobo

Gitanjali Lobo practices at Riverside University Medical Center in Moreno Valley, California.

Gitanjali Lobo's NPI, 1518456243, was assigned on May 8, 2018. Gitanjali Lobo graduated from American University of the Caribbean School of Medicine in 2018. Gitanjali Lobo holds Louisiana license 332503.

Gitanjali Lobo's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Gitanjali Lobo's primary practice is Riverside University Medical Center in Moreno Valley, California. Gitanjali Lobo is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Gitanjali Lobo to 2 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gitanjali Lobo practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Gitanjali Lobo's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Gitanjali Lobo is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Gitanjali Lobo's licenses on file in 3 states: Louisiana, California and Ohio.

Dmand AI lists rheumatoid arthritis among the conditions Gitanjali Lobo treats.

CMS data shows 191 Medicare services from Gitanjali Lobo across 4 procedure codes in 2024, all of them office visits, for 144 Medicare patients. Medicare paid $19,628 for them.

CMS counts 144 Medicare patients who saw Gitanjali Lobo in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Gitanjali Lobo's median patient age at 62, with 80% women.

In 2024, Gitanjali Lobo wrote 1,430 Medicare Part D claims for 368 patients. 86% of them were for generic drugs. CMS names the drug for 1,178 of them, across 23 drugs with 11 or more claims each, at $556,243 in total drug cost. In 2023, CMS named 204 claims across 8 drugs.

Gitanjali Lobo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gitanjali Lobo as offering telehealth.

Dmand AI links 1 paper to Gitanjali Lobo. Gitanjali Lobo's most frequent co-authors are Hiba Ali, MD, William E. Davis and Chad A. Hille, MD.

CMS Open Payments shows 84 general payments to Gitanjali Lobo from 14 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,369.

Gitanjali Lobo graduated from American University of the Caribbean School of Medicine in 2018.

Gitanjali Lobo is in network with 11 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.